🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Arizona › Phoenix

Etid klinik pou Kansè (tout kalite) nan Phoenix, AZ

17 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Ap rekriteEtid obsèvasyon
  • Mayo Clinic Hospital, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • Mayo Clinic Hospital, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Ap rekriteFaz 2
  • Cancer Treatment Centers of America-Phoenix, Phoenix
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Ap rekriteFaz 2/3
  • Mayo Clinic Phoenix, Phoenix
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Banner University Medical Center Phoenix, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Phoenix Childrens Hospital, Phoenix
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Ap rekriteFaz 2
  • Phoenix Children's Hospital, Phoenix
  • Phoenix Children's Hospital, Phoenix
Laj 1 a 39 · Tout sèks · Mizajou Aug 7, 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • Cancer Center at Saint Joseph's, Phoenix
  • Mayo Clinic Hospital in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Mayo Clinic Arizona /ID# 251405, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

Molecular Genetics Studies of Cancer Patients and Their Relatives

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Valleywise Comprehensive Health Center - Phoenix, Phoenix
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT04185935

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • St. Joseph's Hospital and Medical Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • Mayo Clinic Phoenix, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.